Cargando…

A multicentre, prospective, non-interventional study evaluating the safety of dapagliflozin in patients with type 2 diabetes in routine clinical practice in China (DONATE)

BACKGROUND: There are few large-scale studies evaluating the safety of the sodium-glucose cotransporter-2 inhibitor, dapagliflozin, in Chinese patients with type 2 diabetes. DONATE, a multicentre, single-arm, prospective, non-interventional study, is the first real-world study evaluating the safety...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Lixin, Wang, Jing, Li, Li, Yuan, Lin, Chen, Sheng, Wang, Hui, Li, Tonghuan, Qi, Lin, Yang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268430/ https://www.ncbi.nlm.nih.gov/pubmed/37316847 http://dx.doi.org/10.1186/s12916-023-02906-7

Ejemplares similares

Use and effectiveness of dapagliflozin in routine clinical practice: An Italian multicentre retrospective study
por: Fadini, Gian Paolo, et al.
Publicado: (2018)

Similar effectiveness of dapagliflozin and GLP‐1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study
por: Fadini, Gian Paolo, et al.
Publicado: (2019)

A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects
por: Kim, Hyun Chul, et al.
Publicado: (2023)

Effectiveness and safety of dapagliflozin in real-life patients: data from the DAPA-RWE Spanish multicentre study
por: Morales, Cristóbal, et al.
Publicado: (2022)

The intervention dilemma and high burden of children with autism in Guizhou province, Southwest China
por: Liu, Ye, et al.
Publicado: (2022)

Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea
por: Han, Eugene, et al.
Publicado: (2018)

Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study
por: Wu, Jianqiu, et al.
Publicado: (2016)

An exploration of the experience of dapagliflozin in clinical practice
por: Anitha, Anuba Paulvarnan, et al.
Publicado: (2022)

A Network Meta-Analysis of the Dose–Response Effects of Dapagliflozin on Efficacy and Safety in Adults With Type 1 Diabetes
por: Li, Yinhui, et al.
Publicado: (2022)

The development of a legal framework for blood donation and blood safety in China over 24 years
por: Gao, Dajun, et al.
Publicado: (2020)

Efficacy and safety of stratified versus routine prophylaxis in living kidney transplantation from HBsAg+ donors to HBsAg− recipients: protocol for a multicentre, prospective, observational study
por: Wang, Xianding, et al.
Publicado: (2021)

Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add‐on to metformin in patients with type 2 diabetes
por: Müller‐Wieland, Dirk, et al.
Publicado: (2018)

The clinical efficacy and safety of dapagliflozin in patients with diabetic nephropathy
por: Huang, Ying, et al.
Publicado: (2022)

A Multicentre Randomized Clinical Trial on Efficacy and Safety of Huxin Formula in Patients Undergoing Percutaneous Coronary Intervention
por: Wu, Huan-Lin, et al.
Publicado: (2014)

Zarzio(®), biosimilar of filgrastim, in prophylaxis of chemotherapy-induced neutropenia in routine practice: a French prospective multicentric study
por: Nahon, Sophie, et al.
Publicado: (2015)

Blood Donors' Preferences Toward Incentives for Donation in China
por: Wang, Yu, et al.
Publicado: (2023)

Efficacy of dapagliflozin in the treatment of HFrEF with obstructive sleep apnea syndrome (DAHOS study): study protocol for a multicentric, prospective, randomized controlled clinical trial
por: Xie, Liang, et al.
Publicado: (2023)

Optimizing the Detection of Occult Cervical Cancer: A Prospective Multicentre Study in China
por: Li, Yanyun, et al.
Publicado: (2021)

Effect of dapagliflozin on the prognosis of patients with acute myocardial infarction undergoing percutaneous coronary intervention
por: Zhu, Yi, et al.
Publicado: (2022)

Efficacy of Dapagliflozin Combined with Lifestyle Intervention in Obesity Control
por: Dai, Wenhui, et al.
Publicado: (2022)

Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study
por: Fadini, Gian Paolo, et al.
Publicado: (2018)

Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients
por: Wendler, Joerg, et al.
Publicado: (2014)

Protocol for a multicentre, multistage, prospective study in China using system-based approaches for consistent improvement in surgical safety
por: Yu, Xiaochu, et al.
Publicado: (2017)

Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus
por: Saleem, Fatima
Publicado: (2017)

The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China
por: Chen, Jinyan, et al.
Publicado: (2021)

Dosage of antipsychotics in China routine practice
por: Zhang, T., et al.
Publicado: (2021)

Effect of a risk-stratified intervention strategy on surgical complications: experience from a multicentre prospective study in China
por: Yu, Xiaochu, et al.
Publicado: (2019)

Coronary Stenting in Routine Interventional Practice
por: Kelion, Andrew D, et al.
Publicado: (1999)

Multicentre registration of wake-up stroke in China (MCRWUSC): a protocol for a prospective, multicentre, registry-based cohort study
por: Zhang, Zengyu, et al.
Publicado: (2022)

Effıcacy and safety of dapagliflozin on diabetic patients receiving high-doses of insulin
por: Sertbas, Meltem, et al.
Publicado: (2019)

Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions
por: Vart, Priya, et al.
Publicado: (2022)

A Research on the Crisis Spillover Effect of Food Safety Incidents on Competitive Firms: The Influence of Political Connections and Charitable Donations
por: Xiang, Rong, et al.
Publicado: (2021)

Exercise mitigates Dapagliflozin-induced skeletal muscle atrophy in STZ-induced diabetic rats
por: Yang, Xudong, et al.
Publicado: (2023)

Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I/II trial
por: Wang, Huijing, et al.
Publicado: (2022)

Correction: Exercise mitigates Dapagliflozin-induced skeletal muscle atrophy in STZ-induced diabetic rats
por: Yang, Xudong, et al.
Publicado: (2023)

Safety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study
por: Prince, Martin R., et al.
Publicado: (2016)

A Multicentre, Prospective, and Retrospective Registry to Characterize the Use, Effectiveness, and Safety of Dalbavancin in German Clinical Practice
por: Hanses, Frank, et al.
Publicado: (2022)

Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial
por: Wheeler, David C, et al.
Publicado: (2021)

Prospective multicenter non-interventional real-world study to assess the patterns of use, effectiveness and safety of follitropin delta in routine clinical practice (the PROFILE study)
por: Blockeel, Christophe, et al.
Publicado: (2022)

Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction in China: Results From the China PEACE Prospective Study of Percutaneous Coronary Intervention
por: Lu, Yuan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_evgbpre5nhqjfc1nccu2cfngn9